At this point in time, we do not have effective disease-modifying agents for Alzheimer's disease
Referral for accurate and early diagnosis is essential rather than waiting for a clinical diagnosis with more advanced disease
Management of behaviour issues should be non-pharmacological if possible
If absolutely necessary, low dose risperidone may help but monitor; try to wean off the agent when possible
Future diagnosis of AD will be based on biomarker identification such as amyloid or Tau PET and CSF analysis
Host: Dr David Lim | Total time: 24 mins
Guest: Dr Roger Clarnette, Geriatrician; Medical Director, Clinical Trials Division; Consultant Physician, Department of Community and Geriatric Medicine, Fremantle Hospital and Health Service
Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEST
Click here to register for the next one
See omnystudio.com/listener for privacy information.